Diagnostic difficulties of small intestinal neuroendocrine tumors: clinical case

L. P. Kotelnikova , N. A. Shatrova , E. A. Trukhacheva

Perm Medical Journal ›› 2022, Vol. 39 ›› Issue (5) : 144 -149.

PDF
Perm Medical Journal ›› 2022, Vol. 39 ›› Issue (5) :144 -149. DOI: 10.17816/pmj395144-149
Clinical case
research-article

Diagnostic difficulties of small intestinal neuroendocrine tumors: clinical case

Author information +
History +
PDF

Abstract

The objective of the study was to demonstrate the difficulties of diagnosing the neuroendocrine tumor (NET) of the small intestine at the example of a concrete clinical case. In the case presented, clinical manifestations of the disease were nonspecific and the examination began from a low-informative method – multispiral computed tomography (MSCT) without a bolus contrast study that was the reason of wrong diagnosis for 7 months. The detection of the swollen lymph node in the mesentery was interpreted incorrectly; additionally, only endoscopic investigation of the stomach and large intestine was used. By means of MSCT-angiography we succeeded to diagnose not only the lymph node conglomerate in the mesentery, but to reveal a tumor sized 9´15 cm in the ileac wall. Laparoscopy with lymph node biopsy after its morphological study permitted to verify the diagnosis before the surgery.

To reduce the period of diagnostics of small intestinal NET, general practitioners should be informed on specific features of clinical manifestations of the disease and rational diagnostic methods. MSCT-angiography showed its efficiency in detection of small-sized small intestinal NET, and laparoscopy with biopsy of the mesentery lymph node will permit to verify the diagnosis before surgery.

Keywords

small intestinal neuroendocrine tumor / MSCT-angiography / laparoscopy

Cite this article

Download citation ▾
L. P. Kotelnikova, N. A. Shatrova, E. A. Trukhacheva. Diagnostic difficulties of small intestinal neuroendocrine tumors: clinical case. Perm Medical Journal, 2022, 39(5): 144-149 DOI:10.17816/pmj395144-149

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Durleshter V.M., Henrikh S.R., Avakimyan A.V., Dryyaeva L.H., Kirakosyan D.S. Experience of diagnosis and treatment of patients with intestinal neuroendocrine tumor. Nauchnyj vestnik zdravoohraneniya Kubani 2018; 2: 39–50.

[2]

Дуршлер В.М., Генрих С.Р., Авакимян А.В., Дряева Л.Г., Киракосян Д.С. Опыт диагностики и лечения пациентов с нейроэндокринной опухолью тонкой кишки. Научный вестник здравоохранения Кубани. 2018; 2: 39–50.

[3]

Lysanyuk M.V., Maistrenko N.A., Romashenko P.N. The difficulties of diagnosis and choice of treatment tactics of neuroendocrine tumors. Grekov’s Bulletin of Surgery 2018; 177 (1): 76–80.

[4]

Лысанюк М.В., Майстренко Н.А., Ромащенко П.Н. Трудности диагностики и выбора тактики лечения нейроэндокринных опухолей тонкой кишки. Вестник хирургии им. И.И. Грекова 2018; 177 (1): 76–80.

[5]

Lisanyuk M.V., Romashenko P.N., Maistrenko N.A. Features of diagnostics and treatment of patients with neuroendocrine tumors of the small intestine. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2020; 23 (2): 100–109.

[6]

Лысанюк М.В., Ромащенко П.Н., Майстренко Н.А. Особенности диагностики и хирургического лечения больных нейроэндокринными опухолями тонкой кишки. Таврический медико-биологический вестник 2020; 23 (2): 100–109.

[7]

Beltsevich D.G., Melnichenko G.A. Management of patients with differentiated neuroendocrine tumors of jejunum and ileum (according to international guidelines). Endocrine Surgery 2011; 2: 5–17.

[8]

Бельцевич Д.Г., Мельниченко Г.А. Ведение больных с дифференцированными нейроэндокринными опухолями илеоеюнальной локализации (по материалам международных клинических рекомендаций). Эндокринная хирургия 2011; 2: 5–17.

[9]

Watzka F.M., Fotter C., Miederer M., Weber M.M., Schad A., Lang H., Musholt T.J. Surgical treatment of NEN og small bowel: a retrospective analysis. Wold J. Surg. 2016; 40 (3): 749–758.

[10]

Fata C.R., Gonzalez R.S., Liu E., Cates J.M., Shi C. Mesenteric tumor in Endomidgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis. Am. J. Surg. Pathol. 2017; 41 (1): 128–133.

[11]

Fata C.R., Gonzalez R.S., Liu E., Cates J.M., Shi C. Mesenteric tumor in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis. Am. J. Surg. Pathol. 2017; 41 (1): 128–133.

[12]

Clift A.K., Kidd M., Bodei L., Toumpanakis C., Baum R.P., Oberg K., Modlin I.N., Frilling A. Neuroendocrine neoplasms of the small bowel and pancreas. Neuroendocrinology 2020; 110: 444–476.

[13]

Sundin A., Arnold R., Baudin E., Cwikla J.B., Eriksson B., Fanti S., Fazio N., Giammarile F., Hicks R.J., Kjaer A., Krenning E., Kwekkeboom D., Lombard-Bohas C., O’Connor J.M., O’Toole D., Rockall A., Wiedenmann B., Valle J.W., Vullierme M. ENETS Consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine&hybrid imaging. Neuroendocrinology 2017; 105 (3): 121–244.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

230

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/